Stock PHGE BIOMX INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News BiomX Inc.

Equities

PHGE

US09090D1037

Market Closed - Nyse
Other stock markets
 04:10:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.336 USD -1.15% Intraday chart for BiomX Inc. +13.59% +20.00%
Apr. 18 Biomx Inc. Appoints Susan Blum to Its Board of Directors and Member and Chair of the Audit Committee of the Board CI
Apr. 03 Transcript : BiomX Inc., Q4 2023 Earnings Call, Apr 03, 2024

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases
AQ
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
AQ
BiomX Announces the Appointment of Susan Blum to its Board of Directors
AQ
Biomx Inc. Appoints Susan Blum to Its Board of Directors and Member and Chair of the Audit Committee of the Board
CI
BiomX : Introduction
PU
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure
AQ
Transcript : BiomX Inc., Q4 2023 Earnings Call, Apr 03, 2024
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
AQ
BiomX Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024
AQ
Biomx Inc. Announces Board Changes
CI
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing
AQ
BiomX Inc. announced that it has received $50.013969 million in funding from Deerfield Management Company, LLC, AMR Action Fund GP, LLC, Cystic Fibrosis Foundation, Nantahala Capital Management, LLC, OrbiMed Advisors LLC
CI
BiomX Inc. completed the acquisition of Adaptive Phage Therapeutics, Inc.
CI
Sector Update: Health Care Stocks Advance Wednesday Afternoon
MT
Sector Update: Health Care
MT
BiomX Shares Rally After Merger Deal With Adaptive Phage Therapeutics
MT
Transcript : BiomX Inc., Adaptive Phage Therapeutics, Inc. - M&A Call
BiomX : Material Agreement - Form 8-K
PU
BiomX : Introduction
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHGE Stock
  4. News BiomX Inc.